Guglielmini, P., A. Serao, S. Zai, P.L. Piovano, and F. Grosso. 2015. “Second-Line Treatment With Axitinib: An Effective and Well-Tolerated Weapon in the Therapeutic Sequence of Clear Cell Renal Cell Carcinoma”. Working Paper of Public Health 4 (1). https://doi.org/10.4081/wpph.2015.6697.